Open AccessFlea and tick treatment satisfaction, preference, and adherence reported by cat owners in the U.S., U.K., or France who treated their cats with transdermal fluralaner
Author(s) -
Robert P. Lavan,
Robert Armstrong,
Hannah Newbury,
Dorothy Normile,
Céline Hubinois
Publication year - 2021
Publication title -
open veterinary journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.39
H-Index - 10
eISSN - 2226-4485
pISSN - 2218-6050
DOI - 10.5455/ovj.2021.v11.i3.19
Subject(s) - dosing , cats , medicine , veterinary medicine , tick , flea , family medicine , pharmacology
Fluralaner (Bravecto ® ) is an isoxazoline class compound that is the only topically applied systemic ectoparasiticide approved for dosing at up to 12-week intervals for flea and tick control in cats.